Hims Faces GLP-1 Scrutiny While Broader Telehealth Growth Story Evolving [Yahoo! Finance]
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: Yahoo! Finance
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Hims & Hers Health (NYSE:HIMS) is facing a patent infringement lawsuit from Novo Nordisk over its compounded weight loss drugs. The company is also under investigation by the FDA regarding its practices around compounded GLP-1 medications for weight management. The SEC has opened an investigation into the company's disclosures related to these products and its broader weight loss offering. Hims & Hers Health runs a telehealth and consumer wellness platform that connects patients with providers and offers treatments across areas such as hair loss, mental health, and sexual health. Its expansion into compounded GLP-1 weight loss medications has put it directly in the spotlight as demand for obesity treatments grows and regulators scrutinize how these drugs are sourced and marketed. For you as an investor, the cluster of legal and regulatory actions creates a question ma
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- Glancy Prongay Wolke & Rotter LLP Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of InvestorsBusiness Wire
- Law Offices of Howard G. Smith Announces Investigation of Hims & Hers Health, Inc. (HIMS) on Behalf of InvestorsBusiness Wire
- Hims & Hers Health (HIMS) was upgraded by Zacks Research from "strong sell" to "hold".MarketBeat
- Hims & Hers: The Telehealth Growth Story Younger Investors Can't Afford to Ignore [Yahoo! Finance]Yahoo! Finance
- Hims & Hers Health, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]Yahoo! Finance
HIMS
Earnings
- 2/23/26 - Beat
HIMS
Sec Filings
- 3/2/26 - Form 4
- 2/27/26 - Form 144
- 2/25/26 - Form 4
- HIMS's page on the SEC website